FR2794473B1 - Procede de multiplication de cellules souches - Google Patents

Procede de multiplication de cellules souches

Info

Publication number
FR2794473B1
FR2794473B1 FR9907011A FR9907011A FR2794473B1 FR 2794473 B1 FR2794473 B1 FR 2794473B1 FR 9907011 A FR9907011 A FR 9907011A FR 9907011 A FR9907011 A FR 9907011A FR 2794473 B1 FR2794473 B1 FR 2794473B1
Authority
FR
France
Prior art keywords
stem cells
multiplying
multiplying stem
cells
stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9907011A
Other languages
English (en)
French (fr)
Other versions
FR2794473A1 (fr
Inventor
Jacques Alexandre Hatzfeld
Antoinette Klein Hatzfeld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9907011A priority Critical patent/FR2794473B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to PCT/FR2000/001486 priority patent/WO2000075290A1/fr
Priority to US09/980,484 priority patent/US7601534B1/en
Priority to EP00936985A priority patent/EP1181354A1/fr
Priority to CA002375485A priority patent/CA2375485A1/fr
Priority to JP2001502556A priority patent/JP2003501081A/ja
Publication of FR2794473A1 publication Critical patent/FR2794473A1/fr
Application granted granted Critical
Publication of FR2794473B1 publication Critical patent/FR2794473B1/fr
Priority to US12/555,062 priority patent/US20090325289A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR9907011A 1999-06-03 1999-06-03 Procede de multiplication de cellules souches Expired - Fee Related FR2794473B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9907011A FR2794473B1 (fr) 1999-06-03 1999-06-03 Procede de multiplication de cellules souches
US09/980,484 US7601534B1 (en) 1999-06-03 2000-05-30 Method for multiplying stem cells
EP00936985A EP1181354A1 (fr) 1999-06-03 2000-05-30 Procede de multiplication de cellules souches
CA002375485A CA2375485A1 (fr) 1999-06-03 2000-05-30 Procede de multiplication de cellules souches
PCT/FR2000/001486 WO2000075290A1 (fr) 1999-06-03 2000-05-30 Procede de multiplication de cellules souches
JP2001502556A JP2003501081A (ja) 1999-06-03 2000-05-30 幹細胞の増殖工程
US12/555,062 US20090325289A1 (en) 1999-06-03 2009-09-08 Process for the multiplication of stem cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9907011A FR2794473B1 (fr) 1999-06-03 1999-06-03 Procede de multiplication de cellules souches

Publications (2)

Publication Number Publication Date
FR2794473A1 FR2794473A1 (fr) 2000-12-08
FR2794473B1 true FR2794473B1 (fr) 2003-09-26

Family

ID=9546326

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9907011A Expired - Fee Related FR2794473B1 (fr) 1999-06-03 1999-06-03 Procede de multiplication de cellules souches

Country Status (6)

Country Link
US (2) US7601534B1 (https=)
EP (1) EP1181354A1 (https=)
JP (1) JP2003501081A (https=)
CA (1) CA2375485A1 (https=)
FR (1) FR2794473B1 (https=)
WO (1) WO2000075290A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077404A1 (en) 2004-02-13 2005-08-25 Stem Cell Therapeutics Corp. Use of luteinizing hormone (lh) and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis
CA2582567A1 (en) * 2004-10-07 2006-04-13 Stem Cell Therapeutics Corp. Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
KR20080103108A (ko) * 2006-03-17 2008-11-26 스템 셀 테라퓨틱스 코포레이션 신경 장애 치료를 위한 ｌｈ 또는 ｈｃｇ 및 ｅｐｏ의 투여방법
GB201111244D0 (en) * 2011-06-30 2011-08-17 Konink Nl Akademie Van Wetenschappen Knaw Culture media for stem cells
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
ES2579909T3 (es) 2009-02-03 2016-08-17 Koninklijke Nederlandse Akademie Van Wetenschappen Medio de cultivo para células madre epiteliales y organoides que comprenden dichas células madre
WO2011069091A1 (en) 2009-12-04 2011-06-09 Boston Biomedical Research Institute, Inc. Method for cloning pluripotent stem cells
US9164079B2 (en) * 2011-03-17 2015-10-20 Greyledge Technologies Llc Systems for autologous biological therapeutics
US9249394B2 (en) 2011-03-25 2016-02-02 Kyoto University Method for producing epithelial stem cells
GB201721615D0 (en) 2017-12-21 2018-02-07 Koninklijke Nederlandse Akademie Van Wetenschappen Immune cell organoid co-cultures
WO2024259127A2 (en) * 2023-06-13 2024-12-19 The Children's Medical Center Corporation Methods for generating human amniotic membrane and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08205860A (ja) * 1994-01-21 1996-08-13 Usa Government 造血細胞の膨大化および移植方法
DE4422667A1 (de) * 1994-06-30 1996-01-04 Boehringer Ingelheim Int Verfahren zur Herstellung und Züchtung hämatopoetischer Vorläuferzellen
EP0891419A4 (en) * 1996-03-12 2000-03-01 Life Technologies Inc NUTRIENT ADDITIVE FOR HEMATOPOETIC CELL CULTURES
EP0834556A1 (en) * 1996-09-25 1998-04-08 Academisch Ziekenhuis Leiden Methods for culturing cells
JPH10136978A (ja) * 1996-11-08 1998-05-26 Otsuka Pharmaceut Co Ltd 造血幹細胞の培養方法
US6084060A (en) * 1996-12-09 2000-07-04 Imclone Systems Incorporated Composition and method for preserving progenitor cells
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法

Also Published As

Publication number Publication date
WO2000075290A1 (fr) 2000-12-14
EP1181354A1 (fr) 2002-02-27
US7601534B1 (en) 2009-10-13
CA2375485A1 (fr) 2000-12-14
FR2794473A1 (fr) 2000-12-08
US20090325289A1 (en) 2009-12-31
JP2003501081A (ja) 2003-01-14

Similar Documents

Publication Publication Date Title
FR2801899B1 (fr) Dispositif destine a la culture de cellules
EP1349918A4 (en) PLACENTAL STEM CELL COLLECTION TECHNIQUE
FI982183A0 (fi) Menetelmä tehonkulutuksen säätämiseksi
AU2003265094A8 (en) Method for culturing stem cells
DE69921463D1 (de) Verfahren um blutzellzählungen durchzuführen
PL372419A1 (pl) Układ podtrzymujący do płyt ogniw słonecznych
DE60008527D1 (de) Zellproliferation inhibitoren
FI19991646A7 (fi) Menetelmä kasvien kasvun lisäämiseksi
DE60143221D1 (de) Solarzelle
EP1297601A4 (en) MULTIPLE BATTERY SYSTEM AND METHOD
PT1185529E (pt) Pirazolobenzodiazepinas como inibidores de cdk2
FI990526L (fi) Solujen valintamenetelmä
DE69907918D1 (de) Solarzellen-BAUELEMENT
FR2832727B1 (fr) Procede rapide de transformation de cellules competentes
EP1313150A4 (en) SOLAR CELL AND MANUFACTURING PROCESS
FR2794473B1 (fr) Procede de multiplication de cellules souches
EP1100136A4 (en) CELL AND METHOD FOR THE PRODUCTION THEREOF
EP1120846A4 (en) Cell and cell inspecting method
FR2836923B1 (fr) Support pour culture de cellules et procede pour cultiver des cellules.
FR2802340B1 (fr) Structure comportant des cellules photovoltaiques et procede de realisation
IL139322A0 (en) Process for obtaining stem cells
ATE443140T1 (de) Verstärkerelemente für erhöhte translation in pflanzenplastiden
EP1237314A4 (en) METHOD AND CHECK FOR CELL SEARCH
EP1160192A4 (en) METHOD FOR MICROMANIPULATION
AU1409700A (en) Method for counting living cells

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20120229